focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMan Regulatory News (EMG)

Share Price Information for Man (EMG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 259.40
Bid: 257.80
Ask: 258.20
Change: -0.20 (-0.08%)
Spread: 0.40 (0.155%)
Open: 260.00
High: 260.80
Low: 256.40
Prev. Close: 259.60
EMG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

28 Feb 2023 07:01

RNS Number : 2134R
Man Group plc
28 February 2023
 

Man Group plc

Directorate Change

Man Group plc (the "Company") announces that:

- John Cryan, who has served as a director of the Company since January 2015 and as Chair of the Board since January 2020, has decided to retire from the Board towards the end of 2023;

 

- Anne Wade, who has served on the Board as a non-executive director since April 2020, will succeed John Cryan as Chair of the Board upon John's departure in late 2023. At that time, Anne will step down from her position as Chair of the Remuneration Committee but will remain a member, and will also assume the role of Chair of the Nomination Committee. The Company intends to announce the appointment of a new Remuneration Committee Chair in due course, who will take over from Anne on her appointment as Chair of the Board; and

 

- Dame Katharine Barker, who has served on the Board since April 2017, will step down as a non-executive director of the Company and as a member of the Audit and Risk Committee and the Remuneration Committee on 1 April 2023.

 

The Nomination Committee of the Board (the "Committee") was cognisant of the fact that, in line with the UK Corporate Governance Code, John Cryan would be expected to step down from the Board by 15 January 2024, nine years after his appointment as a director of the Company. As a consequence, the Committee has been investing time identifying and considering potential successors for the Board Chair role. This included, with the assistance of an external executive search firm, a thorough preparatory external benchmarking exercise. Following recent discussions, John Cryan has now informed the Board that he intends to retire before the end of this calendar year and the Committee has recommended, and the Board has now approved, the appointment of Anne Wade as the new Chair of the Board, to take effect upon John's retirement.

Richard Berliand, Senior Independent Director, who was responsible for leading the Chair succession process said: "Anne's extensive financial services, asset management and plc Board experience made her an excellent candidate to chair Man Group's Board. Since joining the Board in 2020, she has built strong relationships within the business, as well as with our key stakeholders, and we are looking forward to the Company's next chapter with Anne as Chair."

John Cryan said: "It has been a privilege and a pleasure to serve on the Man Group Board and I would like to thank my fellow Board members and the executive management team for their support throughout my tenure. I am delighted that Anne will be succeeding me as Chair and I feel confident that the Company will continue to progress from strength to strength for many, many years to come.

"I would also like to thank Kate for her excellent contributions to the Board over the past six years. We have benefited significantly from her extensive knowledge of monetary policy and public finances. We are very grateful for her insights and, on behalf of the Board, I wish her all the best."

Luke Ellis, CEO, commented: "It has been a pleasure to work with John over the years. He has a real breadth of corporate experience and his perspectives have been incredibly valuable to me and to the Company. On behalf of everyone at Man Group, I wish him well for the future.

"The strategy for the Company remains unchanged as we continue to strengthen our business for the benefit of our clients, shareholders and stakeholders. We are delighted that Anne will be taking on the role of Chair. She has already been a great contributor on the Board and we look forward to continuing to draw on her extensive experience in the years to come."

Anne Wade commented: "I am delighted to be taking on the role of Chair, working closely with the Board and the executive team to guide Man Group through the next phase of its journey. My time on the Board has already shown me that the Company has a great culture and an abundance of talent. It is well positioned to capitalise on its investment expertise and first-class technology capabilities to deliver outperformance for our clients and excellent value to our shareholders."

Anne is currently a non-executive director of Summit Materials Inc. and a Partner at Leaders' Quest. She was previously a non-executive director at John Laing plc and Holcim Limited and spent 17 years at Capital International where she held various senior roles within research and equity investment, with a focus on the infrastructure sector.

Information equivalent to that required under section 430(2B) of the Companies Act 2006 will be made available on the Company's website.

This announcement is made in compliance with the Company's obligations under Listing Rule 9.6.11R.

 

Enquiries

 

Georgiana Brunner

Head of Communications

+44 (0)20 7144 1239

media@man.com

 

Karan Shirgaokar

Head of Investor Relations

+44 (0)20 7144 1434

investor.relations@man.com

 

Elizabeth Woods

Company Secretary

+44 (0)20 7144 1733

company.secretarial@man.com

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUBUKROVUUUAR
Date   Source Headline
5th Jan 20235:55 pmRNSTransaction in Own Shares
4th Jan 20235:55 pmRNSTransaction in Own Shares
3rd Jan 20235:45 pmRNSTransaction in Own Shares
3rd Jan 20237:00 amRNSTotal Voting Rights
22nd Dec 20225:51 pmRNSTransaction in Own Shares
21st Dec 20226:04 pmRNSTransaction in Own Shares
20th Dec 20225:33 pmRNSTransaction in Own Shares
19th Dec 20226:05 pmRNSTransaction in Own Shares
19th Dec 20222:00 pmRNSDirector/PDMR Shareholding
16th Dec 20225:48 pmRNSTransaction in Own Shares
16th Dec 20222:00 pmRNSDirector Declaration
15th Dec 20226:02 pmRNSTransaction in Own Shares
14th Dec 20225:37 pmRNSTransaction in Own Shares
14th Dec 20223:00 pmRNSDirector/PDMR Shareholding
13th Dec 20225:43 pmRNSTransaction in Own Shares
12th Dec 20225:57 pmRNSTransaction in Own Shares
12th Dec 20223:15 pmRNSDirector/PDMR Shareholding
12th Dec 202212:45 pmRNSHolding(s) in Company
9th Dec 20225:53 pmRNSTransaction in Own Shares
9th Dec 20222:00 pmRNSDirector Declaration
9th Dec 20227:00 amRNSShare buyback programme of up to $125 million
9th Dec 20227:00 amRNSTreasury Share Cancellation & Total Voting Rights
1st Dec 20227:00 amRNSTotal Voting Rights
30th Nov 20225:30 pmRNSHolding(s) in Company
24th Nov 202212:45 pmRNSHolding(s) in Company
1st Nov 20227:00 amRNSTotal Voting Rights
19th Oct 20227:00 amRNSDirectorate Change
19th Oct 20227:00 amRNSTrading statement - Q3 2022
18th Oct 202211:30 amRNSHolding(s) in Company
11th Oct 20224:15 pmRNSHolding(s) in Company
3rd Oct 20227:00 amRNSTotal Voting Rights
14th Sep 20224:45 pmRNSDirector/PDMR Shareholding
13th Sep 20225:39 pmRNSTransaction in Own Shares
12th Sep 20225:45 pmRNSTransaction in Own Shares
9th Sep 20225:40 pmRNSTransaction in Own Shares
9th Sep 20224:35 pmRNSDirector/PDMR Shareholding
8th Sep 20225:43 pmRNSTransaction in Own Shares
7th Sep 20226:03 pmRNSTransaction in Own Shares
7th Sep 20222:00 pmRNSDirector/PDMR Shareholding
6th Sep 20225:23 pmRNSTransaction in Own Shares
5th Sep 20225:44 pmRNSTransaction in Own Shares
5th Sep 20227:00 amRNSTransaction in Own Shares
1st Sep 20226:18 pmRNSTransaction in Own Shares
1st Sep 20223:00 pmRNSTreasury Share Cancellation & Total Voting Rights
1st Sep 20227:00 amRNSTotal Voting Rights
31st Aug 20225:44 pmRNSTransaction in Own Shares
30th Aug 20225:36 pmRNSTransaction in Own Shares
26th Aug 20225:43 pmRNSTransaction in Own Shares
25th Aug 20225:48 pmRNSTransaction in Own Shares
25th Aug 202210:25 amRNSInterim Dividend - Sterling Conversion Rate

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.